Type 2 diabetes is most common in those aged 45 and over, but it is increasingly affecting an increasing number of adolescents, teenagers, and young adults
Presented to the Society for Pediatric Research, San Francisco, CA, 1984
Ozempic contains semaglutide, a GLP-1 receptor agonist, which directly activates a gut-hormone receptor involved in insulin, appetite, and stomach emptying
Liraglutide is taken daily, tends to be easier on the stomach, and costs less
Energy Production: Supporting the creation of ATP (adenosine triphosphate), the primary energy currency of your cells, especially in muscle and heart tissue
Still, GLP-1 use may lead to hundreds of thousands of patients experiencing gastrointestinal side effects, according to the researchers